Viewing nowPME Rosuvastatin Tablets 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.21mg
Tablet · Prescription medication
Pharmascience Korea Co., Ltd.

MFDS item code 201700506 · Approved 2017.01.26 · Insurance code 627600220
Improvement of dyslipidemia, inhibition of atherosclerosis progression, prevention of cardiovascular disease
This medication is used as an adjunctive treatment in cases where diet and exercise alone are insufficient to control primary hypercholesterolemia and mixed dyslipidemia. It is also prescribed to patients with homozygous familial hypercholesterolemia alongside other lipid-lowering therapies to help lower blood cholesterol levels. It particularly helps decline total cholesterol and LDL cholesterol to target levels in patients with hypercholesterolemia, thereby delaying the progression of atherosclerosis. It is also used as an adjunct for diet in pediatric patients aged 10 to 17 years who meet specific criteria for heterozygous familial hypercholesterolemia. It serves as an adjunct to diet for patients with primary dysbetalipoproteinemia and helps reduce the risk of stroke, myocardial infarction, and revascularization procedures in patients at high risk of cardiovascular disease. Therefore, this medication is used to improve hypercholesterolemia and the associated risk of cardiovascular disease.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug, and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response, and may be increased up to a maximum of 20 milligrams once daily. 3. Elderly patients: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. This drug should not be administered to patients with severe renal impairment. Particular caution should be exercised when administering 20 mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: Systemic exposure to rosuvastatin was not increased in patients with a Child-Pugh score of 7 or less, but was increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. This drug should not be administered to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended starting dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or more. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in individuals who are allergic to any of its components. Patients with active liver disease or significantly elevated liver enzyme levels should not take this medication. Patients with muscle disorders or issues related to muscles should also refrain from using this medication. Particularly, individuals with severely impaired renal function, pregnant or breastfeeding women, and women of childbearing potential who are not using appropriate contraception should not take this medication. Dosages exceeding 40 mg are contraindicated in individuals at risk for muscle disorders. Caution should be exercised when using this medication in patients who consume large amounts of alcohol or have a history of liver disease, and regular liver function tests should be performed. Any occurrence of myalgia or muscle weakness should be reported to a healthcare provider immediately, and the medication should be discontinued if necessary. It is advisable to stop using this medication during acute severe illnesses. This medication may rarely cause severe myopathy or ocular myopathy, so it should be discontinued if such symptoms occur. In cases of concomitant use with certain medications, there may be an increased risk of muscle disorders, so exercise caution. It is recommended to perform regular kidney function tests when using 40 mg dosage. In Asian patients, drug concentrations may be higher, requiring dosage adjustment. Children and adolescents can use it, but their growth status should be monitored periodically. While taking this medication, side effects such as liver function abnormalities, increased blood sugar, myalgia, headache, dizziness, and other abnormal symptoms may occur, hence medical consultation should be sought if any adverse effects manifest. In case of severe skin rash or allergic reactions, the medication should be discontinued immediately and appropriate treatment sought. This medication may interact with other medications, so it's essential to inform your healthcare provider of any concurrent medication use. Pregnant or breastfeeding women should not use this medication and women planning to conceive should employ appropriate contraceptive methods. There is no specific antidote for overdose, so immediate medical attention is required.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular muscle weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, drug-induced erythema multiforme, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, fatigue, numbness, sensory disturbances, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container as it may be sensitive to air or moisture. It is advisable to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature. Storing it this way helps maintain the medication's efficacy safely over time.
Yellow colored round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.21mg
Tablet · Prescription medication
Pharmascience Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.